Ketamine-assisted psychotherapy, often called KAP, combines ketamine treatment with structured psychotherapy. For some patients in Twin Falls and across southern Idaho, it may be an option to discuss when depression, anxiety, PTSD symptoms, or other mental health concerns have continued despite prior care.
At H3O Wellness, we believe patients deserve a clear explanation of what KAP involves, what the research does and does not show, and how this approach differs from other treatment options. KAP is not appropriate for every person or every diagnosis, and it should always begin with an individualized clinical evaluation.
Ketamine-Assisted Psychotherapy Combines Medical and Therapeutic Care
KAP is not a separate medication. It is a treatment model that combines ketamine administration with psychotherapy before, during, or after treatment, depending on the clinical plan.
Ketamine can produce temporary changes in perception, mood, and thought patterns. In a medical setting, those effects may provide a context for therapeutic reflection. The psychotherapy component is intended to help patients prepare for treatment, process the experience, and connect what they learn to their ongoing goals and daily life.
The ketamine experience itself is not the goal. KAP is intended to place medical treatment within a broader therapeutic process rather than treating the medication session as a stand-alone event.
Research on KAP is still developing. Early findings are promising for some people with treatment-resistant depression, but current studies vary widely in their treatment models, psychotherapy methods, dosing approaches, and follow-up periods. We do not present KAP as a guaranteed breakthrough, a replacement for all other care, or a universal answer for difficult symptoms.
What a KAP Treatment Plan May Involve
Every patient’s plan should be based on their clinical history, goals, medical needs, and safety considerations. At H3O Wellness, ketamine-assisted psychotherapy begins with determining whether the approach is appropriate for the individual patient.
A KAP plan may include several stages:
A Comprehensive Evaluation
Before recommending treatment, we review your current symptoms, past treatments, medications, medical history, substance-use history, support system, and treatment goals. This process helps us determine whether KAP, another treatment, or a different level of care may be more appropriate.
Our psychiatric services can also help patients review the broader factors that may be affecting their mental health.
Preparation
Preparation sessions help establish realistic expectations and clarify the purpose of treatment. Patients may discuss concerns about the experience, identify areas they want to explore in therapy, and review practical safety considerations.
Preparation is not simply paperwork before treatment. It is an important part of helping patients make an informed decision about whether to proceed.
Medically Supervised Ketamine Treatment
Ketamine is administered in a controlled clinical setting. The details of a session, including the level of therapeutic support and the treatment schedule, should be discussed before care begins.
Some patients experience dissociation, changes in perception, dizziness, nausea, or temporary changes in blood pressure during treatment. These possibilities are part of why screening, supervision, and follow-up matter.
Integration and Ongoing Therapy
Integration refers to the therapeutic work that follows a ketamine session. It may include discussing what came up during treatment, identifying practical coping strategies, and connecting insights to therapy goals, relationships, routines, or other aspects of daily life.
Integration does not guarantee lasting change. It is a structured opportunity to reflect on the experience and determine what ongoing support may be useful.
Who May Be Evaluated for KAP?
H3O Wellness may evaluate KAP for patients experiencing depression, anxiety, PTSD symptoms, and related concerns. A diagnosis alone does not determine whether KAP is appropriate.
The evaluation should consider the severity and pattern of symptoms, previous treatment history, current medications, medical conditions, safety factors, and a patient’s readiness to participate in psychotherapy.
Patients with PTSD symptoms may still benefit from trauma-focused treatment approaches. KAP should not be presented as a replacement for evidence-based trauma therapy, emergency mental health care, or a coordinated treatment plan with the patient’s existing providers.
For people who are comparing several depression-treatment options, our overview of advanced depression treatments in Twin Falls may help frame a conversation about what comes next.
How KAP Differs From Ketamine Treatment Alone
Ketamine treatment and KAP may involve the same medication, but they are different treatment models.
With ketamine treatment alone, the primary focus may be the medication’s clinical effects and the patient’s response over time. KAP places structured psychotherapy at the center of the treatment plan, with preparation and integration intended to support therapeutic work around the medication session.
Ketamine’s psychiatric use, including in KAP, is off-label. This means ketamine is not FDA-approved specifically for depression, anxiety, PTSD, or other psychiatric conditions. Patients should understand this distinction, along with the possible benefits, risks, limitations, and alternatives, before beginning care.
KAP Is Different From SPRAVATO®
KAP should not be confused with SPRAVATO® treatment.
SPRAVATO® is esketamine nasal spray, a distinct medication with FDA-approved uses for adults with treatment-resistant depression. It is administered under specific safety and monitoring requirements.
Ketamine-assisted psychotherapy uses ketamine in an off-label psychiatric context and pairs it with psychotherapy. The treatment options differ in medication, administration, regulatory status, monitoring requirements, and the role psychotherapy plays in the overall plan.
A careful evaluation can help clarify which approach, if any, may be appropriate for your individual circumstances.
Questions to Consider Before Starting KAP
Patients considering KAP should feel comfortable asking direct questions about treatment expectations and safety. Helpful questions may include:
- What symptoms or goals are we trying to address?
- Why is KAP being considered instead of another option?
- What does preparation, treatment, and integration look like in this specific plan?
- Who will provide psychotherapy support?
- What potential side effects or risks should I understand?
- How will we evaluate whether treatment is helping?
- What happens if KAP does not provide enough benefit?
At H3O Wellness, we want patients to have the information they need to make decisions without pressure or unrealistic expectations.
Frequently Asked Questions
What diagnoses is KAP used for at H3O Wellness?
H3O Wellness may evaluate KAP for patients experiencing depression, anxiety, PTSD symptoms, and related mental health concerns. Appropriateness depends on the individual patient’s history, current needs, safety considerations, and treatment goals.
Is KAP the same as receiving ketamine for depression?
No. Ketamine treatment may focus primarily on medication administration and symptom response. KAP incorporates structured psychotherapy before, during, or after ketamine treatment, depending on the care plan.
How many KAP sessions are needed?
There is no universal number of sessions. Treatment plans vary based on the patient’s diagnosis, response, goals, psychotherapy needs, and clinical circumstances. We discuss the expected structure of care during the evaluation process.
What happens if I have a difficult experience during treatment?
Uncomfortable emotions, dissociation, or unexpected thoughts can occur. A difficult experience should be addressed with clinical support and follow-up, rather than being dismissed or automatically treated as a therapeutic benefit. Preparation, monitoring, and integration are important parts of safe care.
Is KAP covered by insurance?
Coverage varies by plan and by the services provided. Because ketamine’s psychiatric use is off-label, patients should not assume that ketamine treatment will be covered. Some psychotherapy services may be eligible for coverage depending on the plan and provider. We encourage patients to verify benefits before beginning care.
Can KAP replace emergency mental health care?
No. KAP is not emergency treatment. If you are in immediate danger, cannot stay safe, or are considering harming yourself, call or text 988, call 911, or go to the nearest emergency department.
Key Takeaways
- Ketamine-assisted psychotherapy combines ketamine treatment with structured psychotherapy and follow-up support.
- KAP typically includes evaluation, preparation, supervised treatment, and integration work.
- Ketamine’s psychiatric use in KAP is off-label.
- Current research is promising but limited, and KAP should not be presented as a guaranteed or universal treatment.
- H3O Wellness may evaluate KAP for depression, anxiety, PTSD symptoms, and related concerns based on individual clinical needs.
- KAP is distinct from both ketamine treatment alone and SPRAVATO® treatment.
Exploring Whether KAP May Be Right for You
KAP may be worth discussing when standard treatment has not provided enough relief, but it is not a one-size-fits-all answer. The right next step begins with understanding your symptoms, treatment history, goals, and the full range of care options available.
At H3O Wellness, we provide individualized psychiatric evaluation and can help you explore whether ketamine-assisted psychotherapy may fit into your treatment plan. To begin the conversation, contact our team.
About H3O Wellness
H3O Wellness is an interventional psychiatry and mental wellness practice with offices in Twin Falls and Burley, Idaho. We provide patient-centered care focused on respect, dignity, thoughtful evaluation, and individualized treatment planning.
Medical Disclaimer
The content of this blog is provided for educational purposes only and does not constitute medical advice. Individual results vary, and no treatment outcome can be guaranteed. The information presented here is not a substitute for professional medical evaluation, diagnosis, or treatment.
Ketamine-assisted psychotherapy may not be appropriate for every patient and involves an off-label psychiatric use of ketamine. Always discuss your medical history, symptoms, and treatment options with a licensed healthcare provider before making healthcare decisions.
Works Cited
Freind, J. M. K., Beserra, F. R., Menezes, B. S., & Mograbi, D. C. (2024). Therapeutic protocols using ketamine and esketamine for depressive disorders: A systematic review. Journal of Psychoactive Drugs, 56(4), 496–512.
Simpson, R. J., & Juruena, M. F. (2026). Effectiveness of ketamine-assisted psychotherapy as a treatment for treatment-resistant depression: A systematic review. Psychopharmacology. Advance online publication.
Swainson, J., McGirr, A., Blier, P., et al. (2021). The Canadian Network for Mood and Anxiety Treatments task force recommendations for the use of racemic ketamine in adults with major depressive disorder. Canadian Journal of Psychiatry, 66(2), 113–125.
U.S. Food and Drug Administration. (2025). SPRAVATO® (esketamine) nasal spray prescribing information.